Modulate Bio is developing next-gen GABA-A positive allosteric modulators to treat neurological disorders, including Essential Tremor, epilepsy and anxiety, without the sedative effects associated with benzodiazepines and neurosteroids.
| Website | http://modulatebio.com |
| Employees | 4 (3 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Neurological Disorders Treatment, Epilepsy Treatment, Anxiety Treatment, Next Generation Therapeutics, Drug Development, Pharmaceutical Research, Therapeutic Drug Development, Nervous System, Novel Therapeutics, Biotechnology, Clinical Development |
Looking for a particular Modulate Bio employee's phone or email?
Modulate Bio Questions
Andrew Thomson is the CEO + Co-founder of Modulate Bio.
3 people are employed at Modulate Bio.
Modulate Bio is based in Cambridge, Massachusetts.
Top Modulate Bio Employees
-
Andrew Thomson
CEO + Co-founder at Modulate Bio
Boston, MA, US32 -
Kevin Hodgetts
Co-Founder at Modulate Bio
Boston, MA, US55+ -
Dario Doller
Chief Scientific Officer (CSO) at Modulate Bio
New York, NY, US33
G2Crowd Trusted
300K+
Plugin Users
